Cresset Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85.5M | Sell |
336,570
-640
| -0.2% | -$149K | 0.31% | 51 |
|
|
2026
Q1 | $82.4M | Sell |
337,210
-25,137
| -7% | -$5.86M | 0.36% | 45 |
|
|
2025
Q4 | $75M | Buy |
362,347
+3,970
| +1% | +$785K | 0.32% | 49 |
|
|
2025
Q3 | $66.5M | Buy |
358,377
+4,079
| +1% | +$699K | 0.29% | 55 |
|
|
2025
Q2 | $54.1M | Sell |
354,298
-36,342
| -9% | -$5.59M | 0.27% | 60 |
|
|
2025
Q1 | $64.8M | Sell |
390,640
-13,620
| -3% | -$2.13M | 0.32% | 51 |
|
|
2024
Q4 | $58.5M | Sell |
404,260
-154,139
| -28% | -$23.9M | 0.28% | 55 |
|
|
2024
Q3 | $90.5M | Buy |
558,399
+7,421
| +1% | +$1.18M | 0.35% | 42 |
|
|
2024
Q2 | $80.5M | Buy |
550,978
+54,848
| +11% | +$8.16M | 0.34% | 42 |
|
|
2024
Q1 | $78.5M | Buy |
496,130
+77,559
| +19% | +$12.3M | 0.38% | 38 |
|
|
2023
Q4 | $65.6M | Sell |
418,571
-28,500
| -6% | -$4.37M | 0.39% | 41 |
|
|
2023
Q3 | $69.6M | Buy |
447,071
+30,233
| +7% | +$4.99M | 0.27% | 48 |
|
|
2023
Q2 | $69M | Buy |
416,838
+307,357
| +281% | +$49.6M | 0.09% | 71 |
|
|
2023
Q1 | $17M | Buy |
109,481
+548
| +0.5% | +$88.5K | 0.34% | 53 |
|
|
2022
Q4 | $13.9M | Sell |
108,933
-44
| -0% | -$7.6K | 0.18% | 64 |
|
|
2022
Q3 | $17.8M | Sell |
108,977
-9,847
| -8% | -$1.67M | 0.23% | 51 |
|
|
2022
Q2 | $20.1M | Buy |
118,824
+6,205
| +6% | +$1.11M | 0.25% | 46 |
|
|
2022
Q1 | $20M | Sell |
112,619
-16,417
| -13% | -$2.79M | 0.21% | 49 |
|
|
2021
Q4 | $22.1M | Buy |
129,036
+7,665
| +6% | +$1.25M | 0.21% | 51 |
|
|
2021
Q3 | $19.6M | Buy |
121,371
+13,757
| +13% | +$2.35M | 0.26% | 39 |
|
|
2021
Q2 | $17.7M | Buy |
107,614
+1,234
| +1% | +$204K | 0.25% | 38 |
|
|
2021
Q1 | $17.5M | Buy |
106,380
+15,741
| +17% | +$2.55M | 0.28% | 38 |
|
|
2020
Q4 | $14.3M | Sell |
90,639
-6,708
| -7% | -$990K | 0.23% | 40 |
|
|
2020
Q3 | $14.5M | Buy |
97,347
+1,013
| +1% | +$150K | 0.27% | 37 |
|
|
2020
Q2 | $13.5M | Buy |
96,334
+24,801
| +35% | +$3.61M | 0.3% | 37 |
|
|
2020
Q1 | $9.38M | Buy |
71,533
+26,231
| +58% | +$3.72M | 0.29% | 33 |
|
|
2019
Q4 | $6.61M | Buy |
45,302
+11,796
| +35% | +$1.6M | 0.18% | 46 |
|
|
2019
Q3 | $4.33M | Buy |
33,506
+3,951
| +13% | +$521K | 0.13% | 75 |
|
|
2019
Q2 | $4.12M | Buy |
29,555
+8,820
| +43% | +$1.22M | 0.13% | 81 |
|
|
2019
Q1 | $2.9M | Buy |
20,735
+5,705
| +38% | +$764K | 0.11% | 43 |
|
|
2018
Q4 | $1.94M | Buy |
+15,030
| New | +$2.1M | 0.12% | 43 |
|
Other funds holding JNJ
Cresset Asset Management's JNJ Position: Q2 2026 in Review
Cresset Asset Management reduced its Johnson & Johnson (JNJ) stake by 0.19% in Q2 2026, selling an estimated $149K and leaving 336,570 shares worth $85.5M. The position accounts for 0.31% of the portfolio, ranked #51.
Cresset Asset Management first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. The position peaked at $90.5M in Q3 2024. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Cresset Asset Management held 336,570 shares of Johnson & Johnson worth $85.5M as of Q2 2026.
- Cresset Asset Management sold 640 Johnson & Johnson shares in Q2 2026, an estimated $149K.
- Johnson & Johnson made up 0.31% of Cresset Asset Management's portfolio in Q2 2026, its #51 holding.
- Cresset Asset Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's Johnson & Johnson position peaked at $90.5M in Q3 2024.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.